创新-话题@MedSci

#创新#

1015篇内容 | 8138人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1286009, encodeId=29c3128600912, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=31省区市累计报告接种新冠病毒疫苗46669.8万剂次，新增接种1718.7万剂次，再创新高, objectType=article, longId=211638, objectId=2e102116382b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e102116382b, replyNumber=0, likeNumber=69, createdTime=2021-05-23, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e102116382b, moduleTitle=31省区市累计报告接种新冠病毒疫苗46669.8万剂次，新增接种1718.7万剂次，再创新高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e102116382b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286008, encodeId=8989128600811, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=罗氏全球加速器在上海启动，引领中国本土医疗行业创新, objectType=article, longId=211521, objectId=ac1d211521de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac1d211521de, replyNumber=0, likeNumber=0, createdTime=2021-05-20, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac1d211521de, moduleTitle=罗氏全球加速器在上海启动，引领中国本土医疗行业创新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac1d211521de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286007, encodeId=de5a128600e7f, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=创新·合作 | 梅斯3M创新沙龙顺利举办！, objectType=article, longId=211515, objectId=6869211515c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6869211515c9, replyNumber=0, likeNumber=79, createdTime=2021-05-20, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6869211515c9, moduleTitle=创新·合作 | 梅斯3M创新沙龙顺利举办！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6869211515c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286006, encodeId=cfe7128600607, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021春季CMEF召开，聚焦创新智慧科技, objectType=article, longId=211286, objectId=e59821128681, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e59821128681, replyNumber=0, likeNumber=66, createdTime=2021-05-15, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e59821128681, moduleTitle=2021春季CMEF召开，聚焦创新智慧科技, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e59821128681)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286005, encodeId=e1d11286005ad, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=ACS Biomater. Sci. Eng.：创新伤口新辅料，或将改善抗生素预防感染新格局, objectType=article, longId=211201, objectId=fb6721120108, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb6721120108, replyNumber=0, likeNumber=66, createdTime=2021-05-14, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb6721120108, moduleTitle=ACS Biomater. Sci. Eng.：创新伤口新辅料，或将改善抗生素预防感染新格局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb6721120108)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286095, encodeId=1b4d12860956f, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=联拓生物合作伙伴ReViral与辉瑞公司签署收购协议，为创新疗法引入大中华区加速！, objectType=article, longId=211192, objectId=78312111928d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78312111928d, replyNumber=0, likeNumber=78, createdTime=2021-05-14, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78312111928d, moduleTitle=联拓生物合作伙伴ReViral与辉瑞公司签署收购协议，为创新疗法引入大中华区加速！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78312111928d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286004, encodeId=d26f128600419, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=公益活动 | 未来可期！针对这种疾病的创新思路，或将成为神经退行性疾病治疗的曙光, objectType=article, longId=211108, objectId=d75121110896, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d75121110896, replyNumber=0, likeNumber=122, createdTime=2021-05-12, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d75121110896, moduleTitle=公益活动 | 未来可期！针对这种疾病的创新思路，或将成为神经退行性疾病治疗的曙光, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d75121110896)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286003, encodeId=80c8128600326, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=JAMA:吸取应对COVID-19的经验教训，加强筛查、控制血压举措创新, objectType=article, longId=211085, objectId=58112110854e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58112110854e, replyNumber=0, likeNumber=69, createdTime=2021-05-12, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58112110854e, moduleTitle=JAMA:吸取应对COVID-19的经验教训，加强筛查、控制血压举措创新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58112110854e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286002, encodeId=da3712860027c, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=NEJM：又添证据——创新药为极难治乳癌患者提高7倍反应率！, objectType=article, longId=210812, objectId=a55c21081222, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a55c21081222, replyNumber=0, likeNumber=52, createdTime=2021-05-06, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a55c21081222, moduleTitle=NEJM：又添证据——创新药为极难治乳癌患者提高7倍反应率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a55c21081222)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286001, encodeId=843c1286001b3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=中国本土创新药卖出“天价”，医疗创新千亿潜力待你发掘！, objectType=article, longId=210643, objectId=348f21064314, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=348f21064314, replyNumber=0, likeNumber=23, createdTime=2021-05-01, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=348f21064314, moduleTitle=中国本土创新药卖出“天价”，医疗创新千亿潜力待你发掘！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=348f21064314)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286000, encodeId=448e12860004b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=PRS：创新！用于腹壁下动脉穿支(DIEP)皮瓣采集的全息可视化技术, objectType=article, longId=210401, objectId=310221040196, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=310221040196, replyNumber=0, likeNumber=64, createdTime=2021-04-25, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=310221040196, moduleTitle=PRS：创新！用于腹壁下动脉穿支(DIEP)皮瓣采集的全息可视化技术, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=310221040196)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285999, encodeId=40c2128599949, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=真实世界研究正当时，创新变革规范加速, objectType=article, longId=210380, objectId=5248210380b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5248210380b5, replyNumber=0, likeNumber=62, createdTime=2021-04-25, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5248210380b5, moduleTitle=真实世界研究正当时，创新变革规范加速, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5248210380b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285998, encodeId=fe921285998b2, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=安进创新胃癌一线疗法bemarituzumab获美国FDA突破性疗法认定, objectType=article, longId=210265, objectId=27f521026528, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27f521026528, replyNumber=0, likeNumber=67, createdTime=2021-04-23, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27f521026528, moduleTitle=安进创新胃癌一线疗法bemarituzumab获美国FDA突破性疗法认定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27f521026528)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285997, encodeId=7639128599e1a, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=NMPA统计年报：7690家药企，创新药临床品种1096 个，生物制品 73 件，128件进口药获批上市！, objectType=article, longId=210262, objectId=a85921026208, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a85921026208, replyNumber=0, likeNumber=74, createdTime=2021-04-23, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a85921026208, moduleTitle=NMPA统计年报：7690家药企，创新药临床品种1096 个，生物制品 73 件，128件进口药获批上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a85921026208)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285996, encodeId=f4171285996da, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=PRS：创新！又快又好地制备出不到0.1mm的超碎颗粒软骨！, objectType=article, longId=210218, objectId=a7a8210218b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7a8210218b5, replyNumber=0, likeNumber=60, createdTime=2021-04-21, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7a8210218b5, moduleTitle=PRS：创新！又快又好地制备出不到0.1mm的超碎颗粒软骨！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7a8210218b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285995, encodeId=4c1712859958d, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2021药物创新与药品监管大变局，中国特色医药监管体系初现, objectType=article, longId=210187, objectId=907521018e22, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=907521018e22, replyNumber=0, likeNumber=83, createdTime=2021-04-21, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=907521018e22, moduleTitle=2021药物创新与药品监管大变局，中国特色医药监管体系初现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=907521018e22)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285992, encodeId=f3861285992e6, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=创新药的创新医学市场之道——梅斯医学参加第六届中华医学事务年会！, objectType=article, longId=210020, objectId=559c21002029, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=559c21002029, replyNumber=0, likeNumber=66, createdTime=2021-04-17, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=559c21002029, moduleTitle=创新药的创新医学市场之道——梅斯医学参加第六届中华医学事务年会！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=559c21002029)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1286027, encodeId=120b128602eb9, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=精鼎医药携手中国医学科学院肿瘤医院建立临床开发创新合作：以患者为中心，提升临床试验的可及性和效率, objectType=article, longId=209986, objectId=90ad209986a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90ad209986a8, replyNumber=0, likeNumber=64, createdTime=2021-04-16, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90ad209986a8, moduleTitle=精鼎医药携手中国医学科学院肿瘤医院建立临床开发创新合作：以患者为中心，提升临床试验的可及性和效率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90ad209986a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285993, encodeId=c49212859933b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=肾性贫血治疗现状仍不理想，临床亟需创新解决方案, objectType=article, longId=209980, objectId=4a1520998075, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a1520998075, replyNumber=0, likeNumber=81, createdTime=2021-04-16, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a1520998075, moduleTitle=肾性贫血治疗现状仍不理想，临床亟需创新解决方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a1520998075)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285991, encodeId=6bcc128599150, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=全球治疗系统性红斑狼疮（SLE）创新双靶生物制剂泰它西普在华率先上市！, objectType=article, longId=209847, objectId=5a7020984efa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a7020984efa, replyNumber=0, likeNumber=87, createdTime=2021-04-13, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a7020984efa, moduleTitle=全球治疗系统性红斑狼疮（SLE）创新双靶生物制剂泰它西普在华率先上市！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a7020984efa)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

创新

2020-05-29

lilianxiang (审核中...)

前往app查看评论内容

#创新#

31省区市累计报告接种新冠病毒疫苗46669.8万剂次，新增接种1718.7万剂次，再创新高

2021-05-23

lilianxiang (审核中...)

前往app查看评论内容

#创新#

罗氏全球加速器在上海启动，引领中国本土医疗行业创新

2021-05-20

lilianxiang (审核中...)

前往app查看评论内容

#创新#

创新·合作 | 梅斯3M创新沙龙顺利举办！

2021-05-20

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021春季CMEF召开，聚焦创新智慧科技

2021-05-15

lilianxiang (审核中...)

前往app查看评论内容

#创新#

ACS Biomater. Sci. Eng.：创新伤口新辅料，或将改善抗生素预防感染新格局

2021-05-14

lilianxiang (审核中...)

前往app查看评论内容

#创新#

联拓生物合作伙伴ReViral与辉瑞公司签署收购协议，为创新疗法引入大中华区加速！

2021-05-14

lilianxiang (审核中...)

前往app查看评论内容

#创新#

公益活动 | 未来可期！针对这种疾病的创新思路，或将成为神经退行性疾病治疗的曙光

2021-05-12

lilianxiang (审核中...)

前往app查看评论内容

#创新#

JAMA:吸取应对COVID-19的经验教训，加强筛查、控制血压举措创新

2021-05-12

lilianxiang (审核中...)

前往app查看评论内容

#创新#

NEJM：又添证据——创新药为极难治乳癌患者提高7倍反应率！

2021-05-06

lilianxiang (审核中...)

前往app查看评论内容

#创新#

中国本土创新药卖出“天价”，医疗创新千亿潜力待你发掘！

2021-05-01

lilianxiang (审核中...)

前往app查看评论内容

#创新#

PRS：创新！用于腹壁下动脉穿支(DIEP)皮瓣采集的全息可视化技术

2021-04-25

lilianxiang (审核中...)

前往app查看评论内容

#创新#

真实世界研究正当时，创新变革规范加速

2021-04-25

lilianxiang (审核中...)

前往app查看评论内容

#创新#

安进创新胃癌一线疗法bemarituzumab获美国FDA突破性疗法认定

2021-04-23

lilianxiang (审核中...)

前往app查看评论内容

#创新#

NMPA统计年报：7690家药企，创新药临床品种1096 个，生物制品 73 件，128件进口药获批上市！

2021-04-23

lilianxiang (审核中...)

前往app查看评论内容

#创新#

PRS：创新！又快又好地制备出不到0.1mm的超碎颗粒软骨！

2021-04-21

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2021药物创新与药品监管大变局，中国特色医药监管体系初现

2021-04-21

lilianxiang (审核中...)

前往app查看评论内容

#创新#

创新药的创新医学市场之道——梅斯医学参加第六届中华医学事务年会！

2021-04-17

lilianxiang (审核中...)

前往app查看评论内容

#创新#

精鼎医药携手中国医学科学院肿瘤医院建立临床开发创新合作：以患者为中心，提升临床试验的可及性和效率

2021-04-16

lilianxiang (审核中...)

前往app查看评论内容

#创新#

肾性贫血治疗现状仍不理想，临床亟需创新解决方案

2021-04-16

lilianxiang (审核中...)

前往app查看评论内容

#创新#

全球治疗系统性红斑狼疮（SLE）创新双靶生物制剂泰它西普在华率先上市！

2021-04-13

科室
- - 订阅+
  - 更多科室
工具
服务